17:10 EDT Autolus Therapeutics (AUTL) files to sell 54.58M American depositary shares for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AUTL:
- Autolus Therapeutics: Strong Q1 Performance and Strategic Expansion Justify Buy Rating
- Autolus Therapeutics Reports Q1 2025 Financial Results
- Strong Market Entry and Strategic Expansion Drive Buy Rating for Autolus
- Autolus Therapeutics reports Q1 EPS (26c), consensus (25c)
- Autolus Therapeutics’ obecabtagene autoleucel conditionally approved by MHRA